Advantest Earns Best Supplier Award From STATS ChipPAC
World-s Top Supplier of Automatic Semiconductor Test Equipment Recognized for Sixth Consecutive Year
Advantest-s V93000 Smart Scale Selected as Primary Test System by HiSilicon Technologies in Shenzhen, China
ASIC Maker Will Use Advantest-s Tester in Engineering and Production of All Its Semiconductor Products
Advantest Enters Protocol-Based Flash Storage Market With New Versatile Test Platform
Company-s Years of Engineering Development Work Yield Flexible Test Solution for All Next-Generation SSDs
Cascade Microtech to Announce Second Quarter Results on August 1, 2013 Conference Call Information
BEAVERTON, OR — (Marketwired) — 07/24/13 — Cascade Microtech, Inc. (NASDAQ: CSCD) will release financial results for its second quarter ended June 30, 2013 at approximately 4:00 p.m. EDT, on Thursday, August 1, 2013. The company will host a conference call beginning at 5:00 p.m. EDT (2:00 p.m. PDT) that same afternoon to discuss these results.A simultaneous audio cast of the conference call may be accessed online from the investor relations page at , or call: 800-884-5695, International: 617
AppliedMicro Announces the X-Weave Family of Connectivity Products for Data Centers and Service Provider Infrastructure
Next-Generation 100G and 200G Ethernet/OTN Products to Bring Unprecedented Levels of High-Density, Low TCO Integration and Performance
Hansen Medical Reports Preliminary Second Quarter 2013 Results
Commercialized Three Robotic Systems in the Quarter; Company Reports Eighth Consecutive Quarter of Procedure Growth
Marjorie Bowen Appointed to Hansen Medical-s Board of Directors
Company-s Board Further Strengthened by Addition of Wall Street Veteran
Hansen Medical and Philips Reinforce Collaboration in Robotic Systems for Endovascular Interventions
Companies Secure Certified Compatibility of Hansen Medical-s Magellan(TM) Robotic System and Philips- Allura Interventional X-ray Systems; Magellan System Is Currently the Only Robotic System on the Market Intended for Use in the Peripheral Vasculature
Will Weinstein Appointed to Hansen Medical-s Board of Directors
Company-s Board Gains Valuable Wall Street Experience
Hansen Medical to Replace Current Debt Facility With New $33 Million, Interest-Only Debt Facility Through 2017
Will Provide Additional Liquidity of Nearly $25 Million Over Next 30 Months Compared to Current Debt Facility; Upon Closing and Funding of This New Debt Agreement, the Company Will Withdraw Its ATM Facility Which Was Not Drawn on or Used